-
1
-
-
34347391035
-
RNA interference to enhance cancer drug discovery
-
E. Iorns, C.J. Lord, N. Turner, A. Ashworth, and A. Utilizing RNA interference to enhance cancer drug discovery Nat. Rev. Drug Discov. 6 2007 556 568
-
(2007)
Nat. Rev. Drug Discov.
, vol.6
, pp. 556-568
-
-
Iorns, E.1
Lord, C.J.2
Turner, N.3
Ashworth, A.4
Utilizing, A.5
-
2
-
-
77649275761
-
Novel RNA-based strategies for therapeutic gene silencing
-
C.R. Sibley, Y. Seow, and M.J. Wood Novel RNA-based strategies for therapeutic gene silencing Mol. Ther. 18 2010 466 476
-
(2010)
Mol. Ther.
, vol.18
, pp. 466-476
-
-
Sibley, C.R.1
Seow, Y.2
Wood, M.J.3
-
3
-
-
77952043572
-
RNAi-based therapeutics-current status, challenges and prospects
-
K. Tiemann, and J.J. Rossi RNAi-based therapeutics-current status, challenges and prospects EMBO Mol. Med. 1 2009 142 151
-
(2009)
EMBO Mol. Med.
, vol.1
, pp. 142-151
-
-
Tiemann, K.1
Rossi, J.J.2
-
4
-
-
49549116014
-
Silencing HIV-1 in vivo
-
F. Kirchhoff Silencing HIV-1 in vivo Cell 134 2008 566 568
-
(2008)
Cell
, vol.134
, pp. 566-568
-
-
Kirchhoff, F.1
-
5
-
-
77956621869
-
Advances in synthetic siRNA-C delivery
-
N. Manjunath, and D.M. Dykxhoorn Advances in synthetic siRNA-C delivery Discov. Med. 9 2010 418 430
-
(2010)
Discov. Med.
, vol.9
, pp. 418-430
-
-
Manjunath, N.1
Dykxhoorn, D.M.2
-
6
-
-
0033910495
-
Polycation liposomes, a novel nonviral gene transfer system, constructed from cetylated polyethylenimine
-
Y. Yamazaki, M. Nango, M. Matsuura, Y. Hasegawa, M. Hasegawa, and N. Oku Polycation liposomes, a novel nonviral gene transfer system, constructed from cetylated polyethylenimine Gene Ther. 7 2000 1148 1155
-
(2000)
Gene Ther.
, vol.7
, pp. 1148-1155
-
-
Yamazaki, Y.1
Nango, M.2
Matsuura, M.3
Hasegawa, Y.4
Hasegawa, M.5
Oku, N.6
-
7
-
-
0035915051
-
A novel non-viral gene transfer system, polycation liposomes
-
N. Oku, Y. Yamazaki, M. Matsuura, M. Sugiyama, M. Hasegawa, and M. Nango A novel non-viral gene transfer system, polycation liposomes Adv. Drug Deliv. Rev. 52 2001 209 218
-
(2001)
Adv. Drug Deliv. Rev.
, vol.52
, pp. 209-218
-
-
Oku, N.1
Yamazaki, Y.2
Matsuura, M.3
Sugiyama, M.4
Hasegawa, M.5
Nango, M.6
-
8
-
-
0038054050
-
Polycation liposome-mediated gene transfer in vivo
-
M. Matsuura, Y. Yamazaki, M. Sugiyama, M. Kondo, H. Ori, M. Nango, and N. Oku Polycation liposome-mediated gene transfer in vivo Biochim. Biophys. Acta 1612 2003 136 143
-
(2003)
Biochim. Biophys. Acta
, vol.1612
, pp. 136-143
-
-
Matsuura, M.1
Yamazaki, Y.2
Sugiyama, M.3
Kondo, M.4
Ori, H.5
Nango, M.6
Oku, N.7
-
9
-
-
1642575109
-
Possible mechanism of polycation liposome (PCL)-mediated gene transfer
-
M. Sugiyama, M. Matsuura, Y. Takeuchi, J. Kosaka, M. Nango, and N. Oku Possible mechanism of polycation liposome (PCL)-mediated gene transfer Biochim. Biophys. Acta 1660 2004 24 30
-
(2004)
Biochim. Biophys. Acta
, vol.1660
, pp. 24-30
-
-
Sugiyama, M.1
Matsuura, M.2
Takeuchi, Y.3
Kosaka, J.4
Nango, M.5
Oku, N.6
-
10
-
-
28444448090
-
Relationships between chemical composition, physical properties and transfection efficiency of polysaccharide-spermine conjugates
-
H. Eliyahu, S. Siani, T. Azzam, A.J. Domb, and Y. Barenholz Relationships between chemical composition, physical properties and transfection efficiency of polysaccharide-spermine conjugates Biomaterials 27 2006 1646 1655
-
(2006)
Biomaterials
, vol.27
, pp. 1646-1655
-
-
Eliyahu, H.1
Siani, S.2
Azzam, T.3
Domb, A.J.4
Barenholz, Y.5
-
11
-
-
3242758245
-
Novel polyamine-dialkyl phosphate conjugates for gene carriers. Facile synthetic route via an unprecedented dialkyl phosphate
-
T. Dewa, Y. Ieda, K. Morita, L. Wang, R.C. MacDonald, K. Iida, K. Yamashita, N. Oku, and M. Nango Novel polyamine-dialkyl phosphate conjugates for gene carriers. Facile synthetic route via an unprecedented dialkyl phosphate Bioconjug. Chem. 15 2004 824 830
-
(2004)
Bioconjug. Chem.
, vol.15
, pp. 824-830
-
-
Dewa, T.1
Ieda, Y.2
Morita, K.3
Wang, L.4
MacDonald, R.C.5
Iida, K.6
Yamashita, K.7
Oku, N.8
Nango, M.9
-
12
-
-
77952573384
-
Liposomal polyamine-dialkyl phosphate conjugates as effective gene carriers: Chemical structure, morphology, and gene transfer activity
-
T. Dewa, T. Asai, Y. Tsunoda, K. Kato, D. Baba, M. Uchida, A. Sumino, K. Niwata, T. Umemoto, K. Iida, N. Oku, and M. Nango Liposomal polyamine-dialkyl phosphate conjugates as effective gene carriers: chemical structure, morphology, and gene transfer activity Bioconjug. Chem. 21 2010 844 852
-
(2010)
Bioconjug. Chem.
, vol.21
, pp. 844-852
-
-
Dewa, T.1
Asai, T.2
Tsunoda, Y.3
Kato, K.4
Baba, D.5
Uchida, M.6
Sumino, A.7
Niwata, K.8
Umemoto, T.9
Iida, K.10
Oku, N.11
Nango, M.12
-
13
-
-
79952803061
-
Dicetyl phosphate-tetraethylenepentaamine-based liposomes for systemic siRNA delivery
-
T. Asai, S. Matsushita, E. Kenjo, T. Tsuzuku, N. Yonenaga, H. Koide, K. Hatanaka, T. Dewa, M. Nango, N. Maeda, H. Kikuchi, and N. Oku Dicetyl phosphate-tetraethylenepentaamine-based liposomes for systemic siRNA delivery Bioconjug. Chem. 22 2011 429 435
-
(2011)
Bioconjug. Chem.
, vol.22
, pp. 429-435
-
-
Asai, T.1
Matsushita, S.2
Kenjo, E.3
Tsuzuku, T.4
Yonenaga, N.5
Koide, H.6
Hatanaka, K.7
Dewa, T.8
Nango, M.9
Maeda, N.10
Kikuchi, H.11
Oku, N.12
-
14
-
-
77951260189
-
Development of double-stranded siRNA labeling method using positron emitter and its in vivo trafficking analyzed by positron emission tomography
-
K. Hatanaka, T. Asai, H. Koide, E. Kenjo, T. Tsuzuku, N. Harada, H. Tsukada, and N. Oku Development of double-stranded siRNA labeling method using positron emitter and its in vivo trafficking analyzed by positron emission tomography Bioconjug. Chem. 21 2010 756 763
-
(2010)
Bioconjug. Chem.
, vol.21
, pp. 756-763
-
-
Hatanaka, K.1
Asai, T.2
Koide, H.3
Kenjo, E.4
Tsuzuku, T.5
Harada, N.6
Tsukada, H.7
Oku, N.8
-
15
-
-
0025341615
-
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
-
A.L. Klibanov, K. Maruyama, V.P. Torchilin, and L. Huang Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes FEBS Lett. 268 1990 235 237
-
(1990)
FEBS Lett.
, vol.268
, pp. 235-237
-
-
Klibanov, A.L.1
Maruyama, K.2
Torchilin, V.P.3
Huang, L.4
-
16
-
-
33846107468
-
Characterization of novel mixed polyethyleneglycol modified liposomes
-
I. Sugiyama, and Y. Sadzuka Characterization of novel mixed polyethyleneglycol modified liposomes Biol. Pharm. Bull. 30 2007 208 211
-
(2007)
Biol. Pharm. Bull.
, vol.30
, pp. 208-211
-
-
Sugiyama, I.1
Sadzuka, Y.2
-
17
-
-
0034000453
-
Tumor vascular permeability and the EPR effect in macromolecular therapeutics
-
H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics J. Control. Release 65 2000 271 284
-
(2000)
J. Control. Release
, vol.65
, pp. 271-284
-
-
Maeda, H.1
Wu, J.2
Sawa, T.3
Matsumura, Y.4
Hori, K.5
-
18
-
-
7444226268
-
Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome
-
N. Maeda, Y. Takeuchi, M. Takada, Y. Sadzuka, Y. Namba, and N. Oku Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome J. Control. Release 100 2004 41 52
-
(2004)
J. Control. Release
, vol.100
, pp. 41-52
-
-
Maeda, N.1
Takeuchi, Y.2
Takada, M.3
Sadzuka, Y.4
Namba, Y.5
Oku, N.6
-
19
-
-
33748370333
-
Enhancement of anticancer activity in antineovascular therapy is based on the intratumoral distribution of the active targeting carrier for anticancer drugs
-
N. Maeda, S. Miyazawa, K. Shimizu, T. Asai, S. Yonezawa, S. Kitazawa, Y. Namba, H. Tsukada, and N. Oku Enhancement of anticancer activity in antineovascular therapy is based on the intratumoral distribution of the active targeting carrier for anticancer drugs Biol. Pharm. Bull. 29 2006 1936 1940
-
(2006)
Biol. Pharm. Bull.
, vol.29
, pp. 1936-1940
-
-
Maeda, N.1
Miyazawa, S.2
Shimizu, K.3
Asai, T.4
Yonezawa, S.5
Kitazawa, S.6
Namba, Y.7
Tsukada, H.8
Oku, N.9
-
20
-
-
33947310094
-
Effective tumor regression by anti-neovascular therapy in hypovascular orthotopic pancreatic tumor model
-
S. Yonezawa, T. Asai, and N. Oku Effective tumor regression by anti-neovascular therapy in hypovascular orthotopic pancreatic tumor model J. Control. Release 118 2007 303 309
-
(2007)
J. Control. Release
, vol.118
, pp. 303-309
-
-
Yonezawa, S.1
Asai, T.2
Oku, N.3
-
21
-
-
9144247189
-
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
-
J. Soutschek, A. Akinc, B. Bramlage, K. Charisse, R. Constien, M. Donoghue, S. Elbashir, A. Geick, P. Hadwiger, J. Harborth, M. John, V. Kesavan, G. Lavine, R.K. Pandey, T. Racie, K.G. Rajeev, I. Röhl, I. Toudjarska, G. Wang, S. Wuschko, D. Bumcrot, V. Koteliansky, S. Limmer, M. Manoharan, and H.P. Vornlocher Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs Nature 432 2004 173 178
-
(2004)
Nature
, vol.432
, pp. 173-178
-
-
Soutschek, J.1
Akinc, A.2
Bramlage, B.3
Charisse, K.4
Constien, R.5
Donoghue, M.6
Elbashir, S.7
Geick, A.8
Hadwiger, P.9
Harborth, J.10
John, M.11
Kesavan, V.12
Lavine, G.13
Pandey, R.K.14
Racie, T.15
Rajeev, K.G.16
Röhl, I.17
Toudjarska, I.18
Wang, G.19
Wuschko, S.20
Bumcrot, D.21
Koteliansky, V.22
Limmer, S.23
Manoharan, M.24
Vornlocher, H.P.25
more..
-
22
-
-
0027997413
-
Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha v beta 3, and alpha 5 beta 1 integrins
-
M. Pfaff, K. Tangemann, B. Müller, M. Gurrath, G. Müller, H. Kessler, R. Timpl, and J. Engel Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins J. Biol. Chem. 269 1994 20233 20238
-
(1994)
J. Biol. Chem.
, vol.269
, pp. 20233-20238
-
-
Pfaff, M.1
Tangemann, K.2
Müller, B.3
Gurrath, M.4
Müller, G.5
Kessler, H.6
Timpl, R.7
Engel, J.8
-
23
-
-
79952180081
-
Promise and challenge of RNA interference-based therapy for cancer
-
F. Petrocca, and J. Lieberman Promise and challenge of RNA interference-based therapy for cancer J. Clin. Oncol. 29 2011 747 754
-
(2011)
J. Clin. Oncol.
, vol.29
, pp. 747-754
-
-
Petrocca, F.1
Lieberman, J.2
-
24
-
-
79955654426
-
Inhibition of Akt(ser473) phosphorylation and rapamycin-resistant cell growth by knockdown of mammalian target of rapamycin with small interfering RNA in vascular endothelial growth factor receptor-1-targeting vector
-
H. Koide, T. Asai, K. Furuya, T. Tsuzuku, H. Kato, T. Dewa, M. Nango, N. Maeda, and N. Oku Inhibition of Akt(ser473) phosphorylation and rapamycin-resistant cell growth by knockdown of mammalian target of rapamycin with small interfering RNA in vascular endothelial growth factor receptor-1-targeting vector Biol. Pharm. Bull. 34 2011 602 608
-
(2011)
Biol. Pharm. Bull.
, vol.34
, pp. 602-608
-
-
Koide, H.1
Asai, T.2
Furuya, K.3
Tsuzuku, T.4
Kato, H.5
Dewa, T.6
Nango, M.7
Maeda, N.8
Oku, N.9
|